The growth in demand of viral-vector-based gene therapies drives continuous efforts to improve viral vector manufacturing.

Driving Manufacturing Improvements Through Viral Vector Advances

Having a clear clinical strategy early on can shave time off overall development projects.

Early Strategizing Tightens Development Timelines

Complex hurdles complicate the development of emerging therapies.

Emerging Therapies Face Development Hurdles

Topic

Matthew Sanders is vice-president, head of Global Drug Substance at GSK, Rixensart, Belgium.

Roland Mainil is director, Technical Development Lead at GSK, Rixensart, Belgium.

Wael Chahim is associate director, Development Unit Head at GSK, Rixensart, Belgium.

Articles

Using a minimum valuable product and process approach would make it is possible to discipline and structure the development of biopharmaceuticals in the fastest way possible.

Introducing a New Concept for Value-Driven Acceleration in Biopharma Development

Editor of Pharmaceutical Technology Europe

There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.

Reformulating Success

Feliza Mirasol is the science editor for 

A simplified downstream process can save time and costs but requires enabling technologies.

Considerations for Simplifying Downstream Processes

 Washington Editor, jillwechsler7@gmail.com.

FDA is highlighting how the Patient-Focused Drug Development program has encouraged active involvement of many patient groups in bringing their perspectives into the process of developing, testing, and approving new medicines.

FDA Expands Patient Input on Drug Development 

A combination of eye imaging techniques and adaptive optics has revealed key details of choroideremia.

Novel Imaging Approach Reveals Key Details About Rare Eye Disease

The dedicated solid-state research and development suite is designed to promote discovery of novel polymorph, salt, and cocrystal forms.

Alcami Adds Solid-State Characterization Capabilities to North Carolina Laboratory

Roquette’s acquisition of Crest Cellulose is designed to reinforce its presence in India and other countries in Asia.

Roquette Acquires Indian Excipient Manufacturer

CytoReason has announced an expanded collaboration deal with Pfizer to deliver AI for drug discovery and development.

CytoReason Announces Expanded Collaboration Deal with Pfizer

Novo Nordisk and Microsoft are collaborating to accelerate drug discovery and development using big data and artificial intelligence. 

Novo Nordisk and Microsoft Collaborate to Accelerate Drug Discovery and Development

Ensysce Biosciences and Quotient Sciences are partnering to develop and test Ensysce’s novel opioid designed to prevent abuse and overdose.